Skip to main content
Premium Trial:

Request an Annual Quote

Deal with Bariatric Support Brings GenoVive's DNA-based Weight Loss Program to Mexico

NEW YORK (GenomeWeb News) – DNA-based nutrition company GenoVive today announced a deal with Bariatric Support to bring GenoVive's weight loss program to Mexico.

GenoVive, based in New Orleans, uses in-home DNA testing to identify an individual's genetic makeup and then customizes diets and exercise plans to help customers lose and manage their weight. Under the terms of the deal, GenoVive and Bariatric may also research how cultural and ethnic differences affect weight gain, loss, and management. Further terms of the deal were not disclosed.

According to GenoVive, Mexico has the second highest incidence of obesity in the world after the US.

GenoVive, founded in 2008, is a division of the Genvis Bio Group and uses a nutrigenomics approach to weight loss, basing its program on how foods affect gene expression and the role of certain genes in weight gain.